A Phase 3 Study Comparing Oral MLN9708 Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Relapsed and/or Refractory Multiple Myeloma
This study is currently recruiting participants.
Verified March 2013 by Millennium Pharmaceuticals, Inc.
Study NCT01564537
Information provided by Millennium Pharmaceuticals, Inc.
First Received on March 22, 2012.
Last Updated on March 11, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
